Skip to Content

PD357 300 (Rezulin 300 mg)

Generic Name: troglitazone

Pill with imprint PD357 300 is White, Elliptical / Oval and has been identified as Rezulin 300 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Rezulin is used in the treatment of diabetes, type 2 and belongs to the drug class thiazolidinediones. There is no proven risk in humans during pregnancy. Rezulin 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PD357 300

Rezulin

Generic Name:
troglitazone
Imprint:
PD357 300
Strength:
300 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Thiazolidinediones
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00071-0357

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide